BioSig Technologies, Inc. STEX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$46.69M-1,560% | -$424.01M-38,481% | -$15.58M-714% | -$20.37M-420% | -$2.81M+17.3% | ||
| -$34.25M-1,056% | -$40.16M-3,383% | -$4.63M-58.4% | -$19.81M-278% | -$2.96M+11.8% | ||
| -$35.75M-1,098% | -$41.63M-3,419% | -$6.11M-107% | -$20.37M-285% | -$2.98M+13.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is BioSig Technologies, Inc.'s revenue?
- BioSig Technologies, Inc. (STEX) generated $40.0K in revenue over the trailing twelve months, up 122.2% year over year.
- Is BioSig Technologies, Inc. profitable?
- BioSig Technologies, Inc. is not currently profitable: it reported a net loss of $506.7M over the trailing twelve months, a -25825.0% net margin.
- What are BioSig Technologies, Inc.'s profit margins?
- Gross margin is 80.1% and operating margin is -32155.0%, with a -25825.0% net margin.
- What is BioSig Technologies, Inc.'s earnings per share?
- BioSig Technologies, Inc.'s diluted EPS over the trailing twelve months is $-9.71.
- Where does BioSig Technologies, Inc.'s income statement data come from?
- Every line is extracted from BioSig Technologies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
